Hardy DJ et al. |
Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview. |
1992 |
Diagn. Microbiol. Infect. Dis. |
pmid:1530914
|
Chu S et al. |
Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial. |
1992 |
J Clin Pharmacol |
pmid:1531484
|
Cynamon MH and Klemens SP |
Activity of azithromycin against Mycobacterium avium infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1329622
|
Knothe H |
[Short-term therapy of acute respiratory and ORL infections with Clarithromycin]. |
1992 |
Z Gesamte Inn Med |
pmid:9022402
|
Bale MJ et al. |
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycin. |
1992 |
J. Clin. Microbiol. |
pmid:1310329
|
Bahal N and Nahata MC |
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin. |
1992 |
Ann Pharmacother |
pmid:1318761
|
Cohen Y et al. |
Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1332586
|
Sifrim D et al. |
Comparison of the effects of midecamycin acetate and clarithromycin on gastrointestinal motility in man. |
1992 |
Drugs Exp Clin Res |
pmid:1292916
|
Dautzenberg B |
[Treatment of atypical mycobacterium infections: current state and therapeutic perspectives]. |
1992 |
Rev Pneumol Clin |
pmid:1296257
|
Peters DH and Clissold SP |
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. |
1992 |
Drugs |
pmid:1379907
|
Calzolari E et al. |
The efficacy of clarythromycin (A-56268, TE-031) in the treatment of genital chlamydial infection. |
1992 |
Drugs Exp Clin Res |
pmid:1306155
|
Klemens SP et al. |
Activity of clarithromycin against Mycobacterium avium complex infection in beige mice. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1336945
|
Ji B et al. |
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. |
1992 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:1338596
|
Omura S et al. |
[Research and development of clarithromycin]. |
1992 |
Yakugaku Zasshi |
pmid:1469609
|
Chu SY et al. |
Clarithromycin pharmacokinetics in healthy young and elderly volunteers. |
1992 |
J Clin Pharmacol |
pmid:1474166
|
Gelber RH et al. |
Clarithromycin at very low levels and on intermittent administration inhibits the growth of M. leprae in mice. |
1992 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:1474290
|
Heifets LB et al. |
Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416852
|
Brown BA et al. |
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416891
|
Biehle J and Cavalieri SJ |
In vitro susceptibility of Mycobacterium kansasii to clarithromycin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416897
|
Chu SY et al. |
Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489187
|
Araujo FG et al. |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489188
|
Gan VN et al. |
Pharmacokinetics of a clarithromycin suspension in infants and children. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489191
|
Denny FW |
Current management of streptococcal pharyngitis. |
1992 |
J Fam Pract |
pmid:1453145
|
Rehg JE |
Anti-cryptosporidial activity of macrolides in immunosuppressed rats. |
1991 Nov-Dec |
J. Protozool. |
pmid:1667930
|
Hughes WT |
Macrolide-antifol synergism in anti-Pneumocystis carinii therapeutics. |
1991 Nov-Dec |
J. Protozool. |
pmid:1818149
|
De Punzio C et al. |
Isolation of Chlamydia trachomatis during IVF-ET. |
1991 Jul-Aug |
Acta Eur. Fertil. |
pmid:1844324
|
Cogo R et al. |
[Dynamics of sIgA concentration in bronchial secretions in patients with COBP treated with clarithromycin]. |
1991 Jan-Dec |
G Ital Chemioter |
pmid:1365564
|
Anderson G |
Clarithromycin in the treatment of community-acquired lower respiratory tract infections. |
1991 |
J. Hosp. Infect. |
pmid:1684979
|
Davey PG |
The pharmacokinetics of clarithromycin and its 14-OH metabolite. |
1991 |
J. Hosp. Infect. |
pmid:1684980
|
King A and Phillips I |
A comparison of the in-vitro activity of clarithromycin, a new macrolide antibiotic, with erythromycin and other oral agents. |
1991 |
J. Hosp. Infect. |
pmid:1684981
|
Wood MJ |
The tolerance and toxicity of clarithromycin. |
1991 |
J. Hosp. Infect. |
pmid:1684982
|
|
Clarithro- and azithromycin--better erythromycins? |
1991 |
Drug Ther Bull |
pmid:1665125
|
Rastogi N et al. |
Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1667250
|
Gu JW et al. |
Bactericidal activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae and streptococcal pathogens. |
1991 |
J Clin Pharmacol |
pmid:1837032
|
Hughes WT and Killmar JT |
Synergistic anti-Pneumocystis carinii effects of erythromycin and sulfisoxazole. |
1991 |
J. Acquir. Immune Defic. Syndr. |
pmid:2016690
|
Rastogi N and Labrousse V |
Extracellular and intracellular activities of clarithromycin used alone and in association with ethambutol and rifampin against Mycobacterium avium complex. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1828135
|
Ji B et al. |
Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1828136
|
Lu MY et al. |
A polymer carrier system for taste masking of macrolide antibiotics. |
1991 |
Pharm. Res. |
pmid:1829521
|
Perronne C et al. |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656860
|
Morgan DK et al. |
A reversed-phase high-performance liquid chromatographic method for the determination and identification of clarithromycin as the drug substance and in various dosage forms. |
1991 |
J Pharm Biomed Anal |
pmid:1831386
|
Dautzenberg B et al. |
Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial. |
1991 |
Am. Rev. Respir. Dis. |
pmid:1832527
|
Rotsch TD et al. |
Determination of clarithromycin as a contaminant on surfaces by high-performance liquid chromatography using electrochemical detection. |
1991 |
Pharm. Res. |
pmid:1833731
|
Jorgensen JH et al. |
Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1834012
|
Truffot-Pernot C et al. |
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complex. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1834015
|
Hamedani P et al. |
The safety and efficacy of clarithromycin in patients with Legionella pneumonia. |
1991 |
Chest |
pmid:1835689
|
Fernandez-Martin J et al. |
Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1836943
|
Gelber RH et al. |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1648889
|
Straneo G and Scarpazza G |
Efficacy and safety of clarithromycin versus josamycin in the treatment of hospitalized patients with bacterial pneumonia. |
1990 Mar-Apr |
J. Int. Med. Res. |
pmid:2140330
|
Fraschini F |
Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis. |
1990 Mar-Apr |
J. Int. Med. Res. |
pmid:2140331
|
Ferrero JL et al. |
Metabolism and disposition of clarithromycin in man. |
1990 Jul-Aug |
Drug Metab. Dispos. |
pmid:1976065
|